Linda Armstrong, Global Head Respiratory Development Unit at Novartis
Linda Armstrong, Global Head Respiratory Development Unit at Novartis

Linda Armstrong

Global Head of the Respiratory and Allergy Development Unit and the US Head of Global Drug Development

Linda Armstrong

Global Head of the Respiratory and Allergy Development Unit and the US Head of Global Drug Development

Linda Armstrong, Global Head Respiratory Development Unit at Novartis

Linda Armstrong is currently the Global Head of the Respiratory and Allergy Development Unit and the US Head of Global Drug Development based in East Hanover NJ, USA. 

Linda has more than 20 years of experience in drug development, patient safety and medical affairs.  She has contributed to the development and launch of many of the most widely used respiratory therapies. Prior to joining Novartis, Linda held leadership roles at Schering-Plough Corporation (now Merck) and Pfizer Inc. 

She is an internist and pulmonologist who completed clinical training at New York University where she was an assistant professor of medicine prior to joining industry.

Linda received her medical degree from Yale University School of Medicine She received her bachelor’s degree from Harvard University.